Aminolevulinic acid and Ibuprofen and Famotidine
Determining the interaction of Aminolevulinic acid and Ibuprofen and Famotidine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Patients exposed to photosensitizing agents may be at increased risk of a phototoxic skin reaction (severe sunburn) during use of aminolevulinic acid. MANAGEMENT: Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid. Some authorities recommend avoiding exposure to any photosensitizing agent for up to 2 weeks after oral administration of aminolevulinic acid, if possible. Patients should also avoid exposure of the eyes and skin to sunlight or bright indoor lights (e.g., examination lamps, operating room lamps, tanning beds, lights at close proximity) for 48 hours after receiving aminolevulinic acid. References "Product Information. Gleolan (aminolevulinic acid)." NX Development Corp, Lexington, KY.
Professional:GENERALLY AVOID: Patients exposed to photosensitizing agents may be at increased risk of a phototoxic skin reaction (severe sunburn) during use of aminolevulinic acid.
MANAGEMENT: Photosensitizing agents (e.g., fluoroquinolones, phenothiazines, retinoids, sulfonamides, sulfonylureas, tetracyclines, thiazide diuretics, griseofulvin, St. John's wort) and topical preparations containing aminolevulinic acid should generally not be administered for 24 hours before and after oral administration of aminolevulinic acid. Some authorities recommend avoiding exposure to any photosensitizing agent for up to 2 weeks after oral administration of aminolevulinic acid, if possible. Patients should also avoid exposure of the eyes and skin to sunlight or bright indoor lights (e.g., examination lamps, operating room lamps, tanning beds, lights at close proximity) for 48 hours after receiving aminolevulinic acid.
- "Product Information. Gleolan (aminolevulinic acid)." NX Development Corp, Lexington, KY.
Generic Name: aminolevulinic acid
Brand name: Gleolan
Synonyms: n.a.
Generic Name: famotidine / ibuprofen
Brand name: Duexis
Synonyms: Famotidine and ibuprofen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aminolevulinic acid-Ibuprofen and oxycodone
- Aminolevulinic acid-Ibuprofen and Phenylephrine
- Aminolevulinic acid-Ibuprofen and pseudoephedrine
- Aminolevulinic acid-Ibuprofen Capsules
- Aminolevulinic acid-Ibuprofen Chewable Tablets
- Aminolevulinic acid-Ibuprofen Immediate Release Tablets
- Ibuprofen and Famotidine-Aminolevulinic Acid (Systemic)
- Ibuprofen and Famotidine-Aminolevulinic Acid Gel
- Ibuprofen and Famotidine-Aminolevulinic Acid Hydrochloride
- Ibuprofen and Famotidine-Aminolevulinic Acid Solution
- Ibuprofen and Famotidine-Aminolevulinic acid topical
- Ibuprofen and Famotidine-Aminomine